Flat Epithelial Atypia: Upgrade Rates and Risk-Stratification Approach to Support Informed Decision Making

The overall risk of upgrade of FEA to malignancy is low at 2.4%; however, the upgrade rate to a higher-risk lesion is nearly 30%. Surveillance rather than surgical excision of FEA can be a reasonable option for patients without a genetic mutation who opt against chemoprevention.